Sectors: Healthcare, Pharma & Life Sciences

Start up

Baker McKenzie with Seamless Therapeutics on Seed Financing

Seamless Therapeutics, a German biotechnology firm, has successfully concluded a USD12.5 million Seed Financing, a university carve-out including equity financing, in-licensing of an innovative patent portfolio from Technische Universität Dresden and hiring of key personnel. Baker McKenzie provided legal and transactional IP advice to Seamless Therapeutics on the financing and in-licensing aspects of the transaction. […]

Deal & transactions

MLLStart! advises Boddy on the acquisition of TrainAway

Swiss-based travel-tech start-up, Boddy, has entered into a binding merger agreement with TrainAway, a Danish company, to form the largest wellbeing network for travelers worldwide.   By affiliating with TrainAway, Boddy will leverage the Danish company’s extensive network of fitness and wellness operators, allowing it to expand its global presence to more than 30 countries […]

Banking & Finance

Advestra advises Lonza on the Placement of CHF 300m Bonds 

Lonza Swiss Finance, a wholly owned subsidiary of the Lonza Group, has suc­cess­fully placed CHF 300 million 2.1% guar­an­teed seni­or bonds due 2029.  Cred­it Suisse, UBS and Zürch­er Kan­ton­al­bank acted as Joint Lead Managers.  Advestra acted as leg­al coun­sel to Lonza. The team included partners Annette Weber (pictured left), Thomas Reut­ter (pictured right) and associate Valérie Bayard (all cap­it­al mar­kets) […]

Deal & transactions

VISCHER advises Versantis on its sale to Gentif

Versantis, a private Swiss-based clinical stage biotechnology company focused on addressing the growing unmet medical needs in liver diseases, is to be sold to Genfit. With this acquisition, Genfit intends to expand its product portfolio with a Phase 2 ready programme based on first-in-class scanning liposome technology, a paediatric programme focused on urea cycle disorder […]

Banking & Finance

Advestra advises Gnothis on Financing Rounds

Advestra has advised Gnothis on all legal aspects related the two financing rounds of nearly CHF 10 million. Gnothis Holding is a com­pany act­ive in the health sec­tor and has closed this fin­an­cing rounds this year. Investors include the invest­ment com­pany Nord­stjernan and the indus­tri­al group Hüb­n­er Group. Gnothis, which is based in Cham, is a pion­eer in the devel­op­ment […]

Banking & Finance

VISCHER advises Mosanna Therapeutics on its Seed Financing Round

Mosanna Therapeutics, a Basel-based biotechnology company, has closed a Seed Financing Round led by Forty51 Ventures. The proceeds will be used for formulation and manufacturing optimization of the molecule MOS118 and for regulatory activities in preparation of the first Phase 1b clinical trial. Mosanna is developing the advanced small molecule MOS118, formerly know as AVE0118, […]

Deal & transactions

Lenz & Staehelin on the acquisition of Nizell Medical

As we announced on February, Promedical, which was acquired earlier this year by a group of investors led by SME Equity Partners and Co-Investor Partners and acting through its parent company, has acquired Lauerz-based Nizell Medical. With this transaction the group further consolidates its position in the Swiss medical consumables market and becomes a leading […]

Banking & Finance

Engimmune Therapeutics raises CHF 15.5m in seed financing round 

Swiss biotech company, Engimmune Therapeutics completes its seed financing round raising CHF 15.5 million, co-led by Pureos Bioventures and Novo Holdings with incubation from BaseLaunch.  Engimmune Therapeutics is a platform company using cutting-edge technologies to engineer highly potent and specific TCR-based therapies for cancer treatment.  Proceeds from the financing will be used to develop novel T-cell […]

Capital Markets

KSA Group on sustainable financing by a CHF 120 million

KSA Group has taken another important step on the way to the new green building “Dreiklang”, KSA’s new ecological construction project. The KSA Group was able to raise CHF 120 million on the capital market by issuing its first green bond. The offering, which was developed under the leadership of UBS and with the Basellandschaftliche […]